Doxazosin structure
Doxazosin
Doxazosin(UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.Target: Adrenergic ReceptorDoxazosin is a long-lasting inhibitor of α1-adrenoceptors that is widely used to treat benign prostatic hyperplasia and lower urinary tract symptoms [1]. doxazosin may have a direct inhibitory effect on cholesterol synthesis independent of the LDL receptor. The inhibition of cholesterol synthesis by doxazosin may cause cells to compensate by upregul
Find 6 Related Holders
APOTEX PHARMACHEM INDIA PVT LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
COHANCE LIFESCIENCES LTD
United States
United States
API Registration Country
API Active
-
Founded in:
2005-09-28 00:00:00 -
Country:
United States
DR. REDDYS LABORATORIES LTD.
Philippines
Philippines
API Registration Country
API Active
-
Founded in:
2008-04-09 00:00:00 -
Country:
Philippines
Unichem Laboratories Ltd
United States
United States
API Registration Country
API Active
Zhejiang Lepu Pharmaceutical Co.,Ltd.
Japan
Japan
API Registration Country
API Active
CHONGQING BIOCARE PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Doxazosin
-
Amitychem
CN1 YR
Contact Supplier -
DKSH
CH1 YR
Contact Supplier -
XIAMEN EQUATION CHEMICAL CO.,LTD
CN1 YR
Contact Supplier -
M A M M TRANDING ENTERPRISE
ZA1 YR
Contact Supplier -
HANGZHOU LEAP CHEM CO., LTD.
CN1 YR
Contact Supplier